Christopher F. Smith on Improving the Lives of Patients with Arthritis
Like PhRMA, improving the lives of people with arthritis is one of the cornerstones of the mission of the Arthritis Foundation.
The Foundation achieves this mission in several ways including help and support for people with arthritis, advocacy and access to critical medications, and research. Every day thousands of individuals with arthritis seek answers to a myriad of questions about this chronic, debilitating and incurable disease.
And they will seek those answers tomorrow, next week, next month and next year and beyond. As a 24/7 resource, the Arthritis Foundation is ready to provide answers.
In response to PhR...
Source: PHRMA - July 29, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Christopher F. Smith on Improving the Lives of Patients
Like PhRMA, improving the lives of people with arthritis is one of the cornerstones of the mission of the Arthritis Foundation.
The Foundation achieves this mission in several ways including help and support for people with arthritis, advocacy and access to critical medications, and research. Every day thousands of individuals with arthritis seek answers to a myriad of questions about this chronic, debilitating and incurable disease.
And they will seek those answers tomorrow, next week, next month and next year and beyond. As a 24/7 resource, the Arthritis Foundation is ready to provide answers.
In response to PhR...
Source: PHRMA - July 29, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Christopher F. Smith
CEOChristopher F. Smith is the CEO of the Arthritis Foundation, Great Lakes Region. The region is comprised of the states of Ohio, Kentucky, Michigan, Central & Western Pennsylvania and West Virginia. He has been CEO since 2011.
The Arthritis Foundation, Great Lakes Region is home to 9.4 million people with arthritis or a related disease. Nearly 39,000 children in the five states have been diagnosed with arthritis and West Virginia is one of 11 states without a single pediatric rheumatologist. By focusing our efforts on advocacy and access, help and support, and research as well as the needs of children with juvenil...
Source: PHRMA - July 29, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news
Mark Richards on Personalized Medicine
YouTube ID: RLbCBgveFEw (Source: PHRMA)
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Mark Richards
Senior Vice President, Management SupervisorMark Richards is a Senior Vice President at KRC Research. He is a leader in KRC’s healthcare, risk and crisis communications, energy, and legal services practices.
Mark is a sociologist who specializes in public opinion and communications research. For the past two decades he has led quantitative and qualitative research projects to identify insights and advise public and private clients. Mark is also an expert on risk and crisis communication, issues management, and controversial facility siting.
Before joining KRC Research, Mark was Senior Research Associate with Bisconti Res...
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
What key benefits of personalized medicine do you think the public needs to know about in order to embrace this approach to health care?
Amy Miller on Personalized Medicine
Submitted by Julie on Thu, 07/24/2014 - 11:49
Share
Email
Print
var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"dr-e0d16a36-b72f-d979-d8a1-314a351971a6"});
$('#shareSocial').click(function(e) { e.preventDefault(); openSocial(); });
function openSocial() {
$('#shareSocial').toggleClass('active');
$('#social').slideToggle();
}
Sign-up for Updates
Subscribe to RSS
Raju Kuche...
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Raju Kucherlapati on Personalized Medicine
YouTube ID: _aC_ABnlUlc (Source: PHRMA)
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Donna Cryer on Personalized Medicine
YouTube ID: K6cmGmAdArA (Source: PHRMA)
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Randy Burkholder on Personalized Medicine
YouTube ID: BW-gBd5ZMjs (Source: PHRMA)
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Amy Miller on Personalized Medicine
YouTube ID: ujy1H9q9xGk (Source: PHRMA)
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Donna R. Cryer, JD
CEODonna Cryer is the President and CEO of the American Liver Foundation, the largest and oldest national non-profit organization serving liver disease patients and their families. Prior to this experience, she served as the chief executive officer of CryerHealth, an international healthcare consulting firm focused on patient engagement and alliance development.
Ms. Cryer’s almost two decades of diverse experiences have provided her with a 360 degree perspective on health care, spanning associations, hospital consulting, PR and clinical trial recruitment firms. Her journey as a patient advocate began with her own liver t...
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Raju Kucherlapati
Professor, Department of GeneticsRaju Kucherlapati, Ph.D., is the Paul C. Cabot Professor in the Harvard Medical School Department of Genetics. He is also a professor in the Department of Medicine at Brigham and Women’s Hospital.
Dr. Kucherlapati was the first Scientific Director of the Harvard Medical School-Partners Healthcare Center for Genetics and Genomics. His research focuses on gene mapping, gene modification, and cloning disease genes. From 1989-2001, Dr. Kucherlapati was the Lola and Saul Kramer Professor of Molecular Genetics and Chairman of the Department at the Yeshiva University Albert Einstein College of M...
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Amy Miller
Executive Vice PresidentFor nearly a decade, Amy Miller, Ph.D., Executive Vice President for the Personalized Medicine Coalition (PMC), has worked with innovators, scientists, providers, and payers to reach consensus on policy issues impacting personalized medicine. Before joining the PMC, Miller worked in the office of the Director of the National Institute of Mental Health where she served as a liaison among the scientific community, the legislative branch, and the consumers of mental health care and their families. A former AAAS fellow, she also served as a domestic policy advisor to Senator Jay Rockefeller. S...
Source: PHRMA - July 24, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Brooke Ringel
Associate Vice PresidentBrooke Ringel is an Associate Vice President for International Affairs at PhRMA, where she focuses on global intellectual property and trade policy and advocacy. Prior to joining PhRMA in June 2013, Brooke practiced international trade law at Kelley Drye & Warren LLP in Washington, specializing in export control and compliance. Brooke has a BA from Stanford University in Political Science/International Affairs and graduated with honors from the George Washington University Law School.
Catalyst ContributorsCompany: PhRMA (Source: PHRMA)
Source: PHRMA - July 14, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Week in Review: Celebrating Patient Health
Before we leave to celebrate the holiday weekend, we wanted to talk about the latest happenings in the biopharmaceutical industry and the importance of celebrating patients.
Researcher and patient advocate Sue Dubman discussed her battle with Parkinson’s disease and participating in clinical trials. There are currently 37 medicines in the pipeline to help treat patients with Parkinson’s disease, but without clinical trial participants, Sue says, new treatments will not be developed to help suffering patients. Thanks to the willingness of brave patients like Sue who enroll in clinical trials, we are making progress and ...
Source: PHRMA - July 3, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
